Composition Comprising Plant Extracts And Uses

Itc Limited
Withdrawn App No 201641006385 Biotechnology

Patent information

IP India · live record
Application number
201641006385
Filing date
24 February 2016
Status
Withdrawn
Publication number
34/2017
Publication type
INA
Invention field
Biotechnology

Abstract

The present disclosure provides compositions comprising plant extracts, which in particular w/w ratios, and weight concentrations exhibits enhanced epithelial wound closure. Also provided are methods of preparing said compositions and uses.

Applicants

1
India
ITC LIMITED ITC LIFE SCIENCES & TECHNOLOGY CENTRE #3, 1st Main, Peenya Industrial Area, Phase 1, Bangalore 560 058, India

Inventors

3
India
HASSAN, SarahITC Life Sciences & Technology Centre #3, 1st Main, Peenya Industrial Area, Phase-1, Bangalore 560 058
India
KHAN, ManishaITC Life Sciences & Technology Centre #3, 1st Main, Peenya Industrial Area, Phase-1, Bangalore 560 058
India
PHULERA, SumitITC Life Sciences & Technology Centre #3, 1st Main, Peenya Industrial Area, Phase-1, Bangalore 560 058

Claims

11
1 A composition comprising: a. Schizandra chinensis fruit extract; and b. at least one extract selected from the group consisting of: i. Ficus carica fruit extract; ii. Callendulla officinalis flower extract; iii. Nymphaea alba flower extract; and iv. combinations thereof, wherein Schizandra chinensis fruit extract to at least one extract w/w ratio is in the range of 1:0.3-1:0.0033.
2 The composition as claimed in claim 1, further comprising suitable carriers, diluents, and excipients.
3 The composition as claimed in any of the claims 1-2, wherein Schizandra chinensis fruit extract weight concentration in said composition is in the range of 500-1500 ppm, and at least one extract weight concentration in said composition is in the range of 5-150 ppm.
4 The composition as claimed in any of the claims 1-2, wherein Schizandra chinensis fruit extract to Ficus carica fruit extract w/w ratio in said composition is in the range of 1:0.03-1:0.0033.
5 The composition as claimed in claim 4, wherein Schizandra chinensis fruit extract weight concentration in said composition is in the range of 500-1500 ppm, and Ficus carica fruit extract weight concentration in said composition is in the range of 5-15 ppm.
6 The composition as claimed in any of the claims 1-2, wherein Schizandra chinensis fruit extract to Callendulla officinalis flower extract w/w ratio in said composition is in the range of 1:0.3-1:0.033.
7 The composition as claimed in claim 6, wherein Schizandra chinensis fruit extract weight concentration in said composition is in the range of 500-1500 ppm, and Callendulla officinalis flower extract weight concentration in said composition is in the range of 50-150 ppm.
8 The composition as claimed in any of the claims 1-2, wherein Schizandra chinensis fruit extract to Nymphaea alba flower extract w/w ratio in said composition is in the range of 1:0.3-1:0.33.
9 The composition as claimed in claim 8, wherein Schizandra chinensis fruit extract weight concentration in said composition is in the range of 500-1500 ppm, and Nymphaea alba flower extract weight concentration in said composition is in the range of 50-150 ppm.
10 A method of preparing a composition as claimed in any of the claims 1-9.
11 A method of epidermal wound closure, said method comprising: a. obtaining a composition as claimed in any of the claims 1-9; and b. contacting said composition with site of epidermal wound, wherein said method promotes epidermal wound closure. , Description:As Attached

Specification

Show full textCollapse

Claims:1. A composition comprising: a. Schizandra chinensis fruit extract; and b. at least one extract selected from the group consisting of: i. Ficus carica fruit extract; ii. Callendulla officinalis flower extract; iii. Nymphaea alba flower extract; and iv. combinations thereof, wherein Schizandra chinensis fruit extract to at least one extract w/w ratio is in the range of 1:0.3-1:0.0033. 2. The composition as claimed in claim 1, further comprising suitable carriers, diluents, and excipients. 3. The composition as claimed in any of the claims 1-2, wherein Schizandra chinensis fruit extract weight concentration in said composition is in the range of 500-1500 ppm, and at least one extract weight concentration in said composition is in the range of 5-150 ppm. 4. The composition as claimed in any of the claims 1-2, wherein Schizandra chinensis fruit extract to Ficus carica fruit extract w/w ratio in said composition is in the range of 1:0.03-1:0.0033. 5. The composition as claimed in claim 4, wherein Schizandra chinensis fruit extract weight concentration in said composition is in the range of 500-1500 ppm, and Ficus carica fruit extract weight concentration in said composition is in the range of 5-15 ppm. 6. The composition as claimed in any of the claims 1-2, wherein Schizandra chinensis fruit extract to Callendulla officinalis flower extract w/w ratio in said composition is in the range of 1:0.3-1:0.033. 7. The composition as claimed in claim 6, wherein Schizandra chinensis fruit extract weight concentration in said composition is in the range of 500-1500 ppm, and Callendulla officinalis flower extract weight concentration in said composition is in the range of 50-150 ppm. 8. The composition as claimed in any of the claims 1-2, wherein Schizandra chinensis fruit extract to Nymphaea alba flower extract w/w ratio in said composition is in the range of 1:0.3-1:0.33. 9. The composition as claimed in claim 8, wherein Schizandra chinensis fruit extract weight concentration in said composition is in the range of 500-1500 ppm, and Nymphaea alba flower extract weight concentration in said composition is in the range of 50-150 ppm. 10. A method of preparing a composition as claimed in any of the claims 1-9. 11. A method of epidermal wound closure, said method comprising: a. obtaining a composition as claimed in any of the claims 1-9; and b. contacting said composition with site of epidermal wound, wherein said method promotes epidermal wound closure. , Description:As Attached

Documents

Sign in to open
Application documents
1 Form 5 [24-02-2016(online)].pdf 24 Feb 2016
2 Form 3 [24-02-2016(online)].pdf 24 Feb 2016
3 Drawing [24-02-2016(online)].pdf 24 Feb 2016
4 Description(Complete) [24-02-2016(online)].pdf 24 Feb 2016
5 Other Patent Document [05-07-2016(online)].pdf 05 Jul 2016
6 Form 26 [05-07-2016(online)].pdf 05 Jul 2016
7 201641006385-Power of Attorney-110716.pdf 29 Jul 2016
8 201641006385-Form 1-110716.pdf 29 Jul 2016
9 201641006385-Correspondence-F1-PA-110716.pdf 29 Jul 2016